Screening and prostate-cancer mortality in a randomized European study - Wikidata - thesis-toulmin - TriplyDB

Screening and prostate-cancer mortality in a randomized European study

Screening and prostate-cancer mortality in a randomized European study

http://www.wikidata.org/entity/Q29617485

about

Screening for Prostate Cancer: Shaping the Debate on Benefits and Harms Screening for prostate cancer Antibiotic prophylaxis for transrectal prostate biopsy Radical prostatectomy versus watchful waiting for prostate cancer Lycopene for the prevention of prostate cancer Screening for prostate cancer Current status of biomarkers for prostate cancer Mortality results from a randomized prostate-cancer screening trial Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion.Relationship between initial PSA density with future PSA kinetics and repeat biopsies in men with prostate cancer on active surveillance Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005 RETRACTED: XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors Clinical validity and utility of genetic risk scores in prostate cancer Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review Screening Coverage Needed to Reduce Mortality from Prostate Cancer: A Living Systematic Review The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements Update on age-appropriate preventive measures and screening for Canadian primary care providers Current status of active surveillance in prostate cancer Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate Cancer Prostate Cancer for the Internist Diagnosis of prostate cancer via nanotechnological approach Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis Treatment options for localized prostate cancer East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians Emerging PSA-based tests to improve screening Using visual aids to improve communication of risks about health: a review Population screening for prostate cancer: an overview of available studies and meta-analysis The role of magnetic resonance imaging in the diagnosis and management of prostate cancer The results of transperineal versus transrectal prostate biopsy: a systematic review and meta-analysis Overdiagnosis and overtreatment of prostate cancer Multiparametric magnetic resonance imaging of the prostate: current concepts Kallikreins as biomarkers for prostate cancer Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening Identifying novel biomarkers through data mining-a realistic scenario?Management of low (favourable)-risk prostate cancer Role of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancer Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel Quality of life issues in men undergoing androgen deprivation therapy: a review

P2860

Q24197953-DBA64816-9D00-426E-9F10-D3D0C94943F7 Q24201690-1B78794E-6DD3-47E3-AB81-62F7E27EE779 Q24234567-737A8851-0025-46D8-8E8F-7AC1E0836620 Q24236564-2A5EF570-32A0-4BF7-A578-2E60BB939E6C Q24241585-943E0E33-58E0-48E7-AC5A-F9CF5C096A0E Q24245476-74CFEE4E-CF51-4404-8D62-73F4EAC2627E Q24600574-A57E6B3B-370D-4624-B895-37ADD6F32ECC Q24601536-614EFC06-ACFF-4CB9-86F2-72D6DD495DD9 Q24608493-2EB36D5F-A8C3-4569-9C63-C62FD10C1087 Q24620320-8C2A1A3E-DBAD-42DD-BD30-476DC4F6183A Q24627957-5CC28851-49CB-4DDA-8E30-B23860ED3123 Q24656098-11C41FDE-A939-44CD-802F-7103A923302D Q24658112-E35413E1-294D-4C3F-940D-A1499A278113 Q26746219-FD227EB9-8BD4-47B2-890A-ED047FE58071 Q26748872-30693E5F-7515-46CC-9148-A0838806FCC6 Q26748873-D6ACAF66-0A23-482F-8CAE-A93F14949B4F Q26750672-06E3AF1A-32DF-433A-94F1-AB812D006A9E Q26765382-E026D4A7-E1C1-426A-8967-A5E28FDA4F30 Q26766307-0D2CC943-09CE-4013-A07C-4AC10B66454E Q26767044-1D2A34E2-173A-4507-8A03-353C36199C25 Q26771721-98E18EB2-3AF1-4E12-8DEF-F4BB307B283E Q26777322-A24C5DF9-C256-43DC-BE52-9F9F686032F0 Q26781093-73AE7620-E64A-49A0-B98D-FEDE4DC41616 Q26825653-241F653E-6215-47E3-8E65-43986192D3CD Q26827438-8A5F34BC-23F3-4928-A80D-8B1E2EAB598C Q26828563-C4C93B33-370C-40E8-A4F8-BB1615477B56 Q26829289-C07DA49E-BFAA-4702-8121-A880DDA51681 Q26829319-87F42AA6-0F20-4D6A-A8E3-AB28EAF64CA8 Q26849794-F45C4B69-CECE-4B83-81DF-BBE8DA69CF04 Q26858924-E935A1B0-FC2F-4D95-BC4D-5F39ADC715A1 Q26859596-B54769FA-25A1-4DD3-BC03-0D5E18947260 Q26859699-542CC1D1-92F2-41DB-A5B9-8008B166986A Q26862434-99ECD022-AE79-4773-8AFE-127E2EB25AED Q26864419-76260D46-5452-4C9C-9A2E-B1FA1715BECE Q26995754-1C0B16DB-43B5-4CF6-B2E1-B7BC4E5F3891 Q26996501-EFF510EA-53B3-4D13-887F-C937F6A36021 Q26998938-5060A51D-3D9B-43CA-A13D-054734BBD06E Q27001043-2A92AFB6-9D78-4101-B3C1-446B8AF2779F Q27001399-2F05F475-61BC-4F59-9EA8-FA0D44CD8FF7 Q27002887-1C275FA9-3B46-42CC-A1EB-A21B2F1B2A1E

P2860

Screening and prostate-cancer mortality in a randomized European study

http://www.wikidata.org/entity/Q29617485

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Screening and prostate-cancer mortality in a randomized European study

@ast

Screening and prostate-cancer mortality in a randomized European study

@en

type

label

Screening and prostate-cancer mortality in a randomized European study

@ast

Screening and prostate-cancer mortality in a randomized European study

@en

prefLabel

Screening and prostate-cancer mortality in a randomized European study

@ast

Screening and prostate-cancer mortality in a randomized European study

@en

P1433

Q29617485-51EF868A-D63F-4306-BD8D-3B6FAC139103

P1476

Q29617485-2A86DBBC-AC7B-431B-A6CD-65C2BC681365

P2093

Q29617485-0555FAAC-D050-4CE6-87B5-341C05D770E6

Q29617485-07A4E18A-EBD0-4CA2-8981-512F9305CE9A

Q29617485-11D17F34-F3CA-4FEC-A244-BB4CC6C27028

Q29617485-160C2AEC-D508-4C36-8428-C4EFD82D2CB8

Q29617485-37C9E5E3-1C3A-4B0F-B6D3-CC953CE652CC

Q29617485-42D8D4E2-50A5-4594-BE39-CF49921213E5

Q29617485-4586E186-49B4-4BF9-BCCB-1352EFDDBD4F

Q29617485-4A0353E0-698E-4120-93C2-FFBD48A794D1

Q29617485-4CC24197-C247-4B05-9619-19715791D494

Q29617485-4FFEA87D-8B28-412D-95A8-DB4A56BC8781

P304

Q29617485-20B7153A-6FB1-4716-9D12-E969477C8861

P31

Q29617485-BE45CA60-EB2F-4330-BEB7-39FE0041272A

P3181

Q29617485-AB316E84-F6B9-46F7-997E-CBAA284E43D7

P356

Q29617485-C35F584A-EB90-4FE5-AD85-DBBD8E937E45

P407

Q29617485-388EAB39-1EBA-4B28-95D5-19444D14A872

P433

Q29617485-41E80F80-47A2-4E63-95B6-43CE5705CF9D

P478

Q29617485-E8D1FE58-05AB-4D54-BCC5-9F941170A541

P50

Q29617485-1DDCDD69-1DDD-4A7E-9A90-7D28319B198A

Q29617485-B477ABCC-DF28-4798-AFD0-2537F6AA9955

Q29617485-DB6A2F48-5DBF-4BC4-89CA-5380CF9D9FCA

P577

Q29617485-29118900-410C-4EC1-8DF3-7F3C5B7D116A

P5875

Q29617485-F9457819-944F-45A9-81B8-B2760C43263B

P698

Q29617485-92BD1593-211F-4898-9662-7056E49849C3

P3181

P356

P1433

The New England Journal of Medicine

P1476

Screening and prostate-cancer mortality in a randomized European study

@en

P2093

Antonio Berenguer

http://www.w3.org/2001/XMLSchema#string

Bert G Blijenberg

http://www.w3.org/2001/XMLSchema#string

Chris H Bangma

http://www.w3.org/2001/XMLSchema#string

ERSPC Investigators

http://www.w3.org/2001/XMLSchema#string

Franz Recker

http://www.w3.org/2001/XMLSchema#string

Fritz H Schröder

http://www.w3.org/2001/XMLSchema#string

Gunnar Aus

http://www.w3.org/2001/XMLSchema#string

Harry J de Koning

http://www.w3.org/2001/XMLSchema#string

Jonas Hugosson

http://www.w3.org/2001/XMLSchema#string

Liisa Määttänen

http://www.w3.org/2001/XMLSchema#string

P304

1320-1328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1324711

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA0810084

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

360

http://www.w3.org/2001/XMLSchema#string

P50

Arnauld Villers

P577

2009-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24211499

http://www.w3.org/2001/XMLSchema#string

P698

19297566

http://www.w3.org/2001/XMLSchema#string